New Results
Adaptive vs continuous cancer therapy: Exploiting space and trade-offs in drug scheduling
Jill A. Gallaher, Pedro M. Enriquez-Navas, Kimberly A. Luddy, Robert A. Gatenby, Alexander R. A. Anderson
doi: https://doi.org/10.1101/128959
Jill A. Gallaher
1H. Lee Moffitt Cancer Center, Integrated Mathematical Oncology (Tampa, FL, United States)
Pedro M. Enriquez-Navas
2H. Lee Moffitt Cancer Center, Cancer Imaging and Metabolism (Tampa, FL, United States)
Kimberly A. Luddy
2H. Lee Moffitt Cancer Center, Cancer Imaging and Metabolism (Tampa, FL, United States)
Robert A. Gatenby
1H. Lee Moffitt Cancer Center, Integrated Mathematical Oncology (Tampa, FL, United States)
Alexander R. A. Anderson
1H. Lee Moffitt Cancer Center, Integrated Mathematical Oncology (Tampa, FL, United States)
Article usage
Posted May 30, 2017.
Adaptive vs continuous cancer therapy: Exploiting space and trade-offs in drug scheduling
Jill A. Gallaher, Pedro M. Enriquez-Navas, Kimberly A. Luddy, Robert A. Gatenby, Alexander R. A. Anderson
bioRxiv 128959; doi: https://doi.org/10.1101/128959
Subject Area
Subject Areas
- Biochemistry (11730)
- Bioengineering (8743)
- Bioinformatics (29179)
- Biophysics (14964)
- Cancer Biology (12080)
- Cell Biology (17399)
- Clinical Trials (138)
- Developmental Biology (9417)
- Ecology (14174)
- Epidemiology (2067)
- Evolutionary Biology (18294)
- Genetics (12233)
- Genomics (16791)
- Immunology (11858)
- Microbiology (28051)
- Molecular Biology (11575)
- Neuroscience (60919)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4955)
- Plant Biology (10422)
- Synthetic Biology (2881)
- Systems Biology (7338)
- Zoology (1650)